| Literature DB >> 29915822 |
Shuhei Kosono1, Akihiro Kasai1, Sumika Komaba1, Teruhiko Matsubara2, Toshinori Sato2, Daisuke Takahashi1, Kazunobu Toshima1.
Abstract
Among a series of chemically synthesized fucoidan derivatives (1-9), 5 was found for the first time to bind to influenza virus hemagglutinins (HAs) and inhibit hemagglutination activity. In addition, a designed C3-symmetric tripodal ligand 10, synthesized with three sulfated oligofucoside moieties of 5, exhibited much greater hemagglutination inhibition activity than 5. A plaque assay using MDCK cells demonstrated that 10 effectively inhibited influenza virus infection.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29915822 DOI: 10.1039/c8cc03865a
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222